Life Sciences

Found results: 11545

Other life sciences

Cellulite injection: clinical studies continue

As part of a phase I clinical trial, the introduction of collagenase into the posterior surface of the thighs after a day led to a 77% decrease in the severity of cellulite. In a few months, the developers of the method plan to start phase II.

17.04.2013
Nanotechnology

Nanodiamonds against triple negative breast cancer

The targeted delivery system of nanodiamond-based chemotherapy drugs increases the effectiveness of treatment and reduces the risk of side effects of treatment of triple-negative breast cancer characterized by particular aggressiveness.

17.04.2013
Other life sciences

We are not beavers. Beavers are not us

American bioengineers have developed a technology for producing food starch from sawdust. So far, it costs $50,000 per kilogram, but scientists suggest reducing the cost of a portion of carbohydrates to 50 cents per person per day.

17.04.2013
Biomedicine

A bolt with a left thread was found on the tricky microbes

A new broad–spectrum antibiotic, active against "super-microbes" - microorganisms resistant to the action of other antibacterial agents, and not addictive to bacteria, has been successfully tested on animals.

17.04.2013
Other life sciences

Telomerase in 3D format

The creation of the first three-dimensional map of the telomerase enzyme molecule, which plays a crucial role in aging and cell malignancy, opens up new opportunities in the fight against various diseases.

16.04.2013
Prolonging youth

The only reliable remedy for senile dementia

The analysis of a vast array of data has refuted the widespread opinion that medications, vitamins, dietary supplements and physical activity slow down the age-related deterioration of cognitive function. The only effective means are mental exercises.

16.04.2013
Cellular technologies

A trap for iPSC

A microfluidic chip for separating a mixture of different cell types, based on easily distinguishable differences in their adhesive properties, can significantly increase the number of stem cells obtained by reprogramming.

16.04.2013
Biomedicine

Two - faced interferon

Contrary to popular belief, type I interferons do not always help in the fight against viruses. In cases of pathogens prone to chronization, they contribute to the formation of persistent infections.

16.04.2013
Cellular technologies

Bioengineered kidney works in the body!

The rat test was successful: the kidney filters blood and produces urine. Although so far the bioengineering body is not up to the usual in terms of the quality of work.

15.04.2013
Other life sciences

The first successful uterus transplant

The first case of pregnancy of a woman with a transplanted uterus in the history of medicine has been recorded. However, the final success can be reported in eight months…

15.04.2013
Biomedicine

A new candidate for cancer drugs

A molecule with the classification number AGI-6780 has been named as a promising candidate for the role of a possible targeted (that is, directed against well-marked molecular targets) anticancer drug.

15.04.2013
Other life sciences

Alzheimer's disease: the missing link found

The Scripps Institute has found a link between the toxic effects of beta-amyloid and tau protein and warns against euphoria about metformin.

15.04.2013
Cellular technologies

Cocktail for the heart

The protein cocktail developed by the specialists of the Mayo Clinic makes it possible to transform bone marrow stem cells into cardiopoietic stem cells, the introduction of which improves heart function in patients with heart failure.

15.04.2013
Other life sciences

A brain that can be seen through

The technology for creating a transparent brain was called Clarity. With its help, you can examine each neuron in detail without damaging the structure of the brain at all. If you add a fluorescent marker, you can see the RNA in its present place.

12.04.2013
Biomedicine

RNA interference against cancer

The results of the first phase I clinical trial of the drug, which is based on the phenomenon of RNA interference, indicate the safety and potential effectiveness of drugs of this class.

12.04.2013
Biomedicine

Two-stage immunotherapy for ovarian cancer

According to the results of the phase I clinical trial, 75% of patients with the last stages of recurrent ovarian cancer responded to the new two-stage immunotherapy. At the same time, one of them went into full remission.

12.04.2013